Loading clinical trials...
Loading clinical trials...
A Randomized, Double Blind Multi Center Dose Ranging Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo In The Adjunctive Treatment Of Post Surgical Pain After Primary Inguinal Hernia Repair
Conditions
Interventions
Pregabalin
placebo
+2 more
Locations
42
United States
Pfizer Investigational Site
Birmingham, Alabama, United States
Pfizer Investigational Site
Glendale, California, United States
Pfizer Investigational Site
Laguna Hills, California, United States
Pfizer Investigational Site
Pasadena, California, United States
Pfizer Investigational Site
Lake Worth, Florida, United States
Pfizer Investigational Site
Pensacola, Florida, United States
Start Date
January 1, 2008
Primary Completion Date
June 1, 2009
Completion Date
September 1, 2009
Last Updated
January 25, 2021
NCT04577690
NCT07360392
NCT05722002
NCT07512141
NCT06757075
NCT07473583
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions